Lawrence Schimmel - 02 Apr 2022 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Reporting relationship: Chief Medical Information Off
Issuer ticker: NUTX
Reported as of: 02 Apr 2022
Net transaction value: -$3,037,489,436
SEC form: 4
Accepted by SEC: 02 Aug 2022, 14:26:00 UTC
Prior SEC filing: 08 Apr 2022
Next SEC filing: 04 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Lawrence Schimmel

Key filing fact

Lawrence Schimmel filed Form 4 for Nutex Health, Inc. (NUTX) on 02 Aug 2022.

Key facts

This page summarizes Lawrence Schimmel's Form 4 filing for Nutex Health, Inc. (NUTX).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 02 Aug 2022, 14:26.

Change

Previous filing in this sequence was filed on 08 Apr 2022.
Current net transaction value: -$3,037,489,436.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUTX transaction

Common Stock

Conversion of derivative security

Transaction value: $30,375
Shares: +19,597
Change %: +8.4%
Price: $1.55
Shares after: 253,645
Date: 02 Apr 2022
Ownership: Direct

NUTX transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $15,188
Shares: +9,799
Change %: +3.9%
Price: $1.55
Shares after: 263,444
Date: 02 Apr 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUTX transaction Derivative

Convertible Promissory Note

Conversion of derivative security

Transaction value: $3,037,535,000
Shares: -30,375
Change %: -100%
Price: $100000.00^*
Shares after: 0
Date: 02 Apr 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,597
Exercise price: $1.55
Footnotes: F1

NUTX transaction Derivative

Warrant

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: -9,799
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 02 Apr 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,799
Exercise price: $1.55
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.

Footnote F2

Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.